This site is intended for health professionals only
Hospital Healthcare Europe
Register
Login
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
News
In depth
Views
Conference reports
Reviews & Research
Practice
Health technology
Sustainability
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Haematology
Immunology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Events
Upcoming events
On-demand learning
Clinical Excellence Catch-up
Partners
Register
Login
Home
>
Editor’s pick
Editor’s pick
NicOx’s June 16 Shareholder Meetings
Shire files suit against Anchen Pharmaceuticals, Inc. and Anchen, Inc.
FDA orders asthma drug label change
Pivotal Phase III trial of Novartis drug Afinitor met primary endpoint
Americans choose drugs over talk
Regulators pass osteoporosis drug
Data at ASCO shows promising outcome of Novartis drugs
Evolva announces change in management team
New mechanism of pancreatic cancer discovered
NICE rejects Novartis asthma drug
Shire Receives LIALDA Paragraph IV Notice Letter
Vyvnase “effective” for ADHD teens
« Previous
1
…
64
65
66
67
68
…
302
Next »
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: